Drug Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ALGS | D | Aligos Therapeutics, Inc. | -4.24 | |
ITCI | C | Intra-Cellular Therapies Inc. | -2.19 | |
TVGN | F | Tevogen Bio Holdings Inc. | -1.64 | |
RPRX | D | Royalty Pharma plc | -1.22 | |
LDOS | A | Leidos Holdings, Inc. | -0.69 | |
AMPH | F | Amphastar Pharmaceuticals, Inc. | -0.47 | |
ME | D | 23andMe Holding Co. | -0.46 | |
CLNN | D | Clene Inc. | -0.41 | |
CERT | D | Certara, Inc. | -0.06 | |
ENZ | F | Enzo Biochem, Inc. | 0.00 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Semiconductor Equipment & Materials
Related Stock Lists:
Biopharmaceutical
Biotechnology
Life Sciences
Medicine
Biology
Cancer
Health Sciences
Medication
Neurological Disorders
Pharmaceutical
Pharmaceutical Products
Pharmacology
Technology Solutions
Acid
Active Pharmaceutical Ingredients
Aging Associated Diseases
Alcohol
Alzheimer's Disease
Antibodies
Antiviral Therapies
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SURI | D | Simplify Exchange Traded Funds Simplify Propel Opportunities ETF | 3.7 | |
PJP | A | PowerShares Dynamic Pharmaceuticals | 2.94 | |
PSCH | C | PowerShares S&P SmallCap Health Care Portfolio | 2.91 | |
XPH | D | SPDR S&P Pharmaceuticals ETF | 2.19 | |
TMFS | B | Motley Fool Small-Cap Growth ETF | 1.96 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Semiconductor Equipment & Materials
Related Stock Lists:
Biopharmaceutical
Biotechnology
Health Sciences
Life Sciences
Medication
Pharmaceutical
Pharmacology
Active Pharmaceutical Ingredients
Alcohol
Clinical Medicine
Hepatitis
Liver Disease
Medicine
Non Alcoholic Fatty Liver Disease
Pharmaceutical Sciences
Pharmacy
Steatohepatitis
Antibodies
Antiviral Therapies
Artificial Intelligence
- Drug Development
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles